GreenLight Biosciences (NASDAQ:GRNA – Get Rating) is one of 275 public companies in the “Biological products, except diagnostic” industry, but how does it compare to its competitors? We will compare GreenLight Biosciences to related companies based on the strength of its dividends, profitability, risk, institutional ownership, analyst recommendations, earnings and valuation. Analyst Recommendations This is […]